Bristol-Myers Squibb Quick Analysis

Bristol-Myers Squibb Quick Analysis

#Bristol-Myers Squibb could be on track to break out. The drugmaker said Monday that its current pipeline of drugs could generate $25 billion in annual revenue, enough to replace lost revenue from expired patents by 2030. Bristol-Myers Squibb closed up 0.460 at 65.430. Volume was 18% above average (neutral) and Bollinger Bands were 4% narrower than […]